About ACP Pharmaceuticals
ACP Pharmaceuticals Pty Ltd is an Australian pharmaceutical company operating within Therapeutic Goods Administration (TGA) regulatory requirements. The company is authorised to manufacture and sponsor prescription-only medicines, including products classified as Schedule 4 and Schedule 8 substances under applicable Commonwealth and state legislation.
Corporate & Regulatory Position
ACP operates within established pharmaceutical governance frameworks and maintains responsibility for nominated medicinal cannabis products supplied in Australia. As sponsor, ACP holds accountability for maintaining regulatory records, documentation integrity, and ongoing compliance obligations in accordance with Therapeutic Goods Administration (TGA) requirements.
Governance Framework
ACP maintains structured internal systems to support:
- Controlled documentation
- Batch record review
- Release authorisation procedures
- Stability data management
- Regulatory record retention
All activities are conducted within formal quality management systems designed to ensure traceability and compliance continuity.
Independent Analytical Verification
Products manufactured or sponsored by ACP are supported by independent analytical testing. ACP works with accredited third-party laboratories, including Pharmalytics, to verify product specifications such as cannabinoid profile, microbiological compliance, heavy metals, and other required parameters. Analytical results are reviewed as part of the formal release process and maintained within regulatory documentation systems.
Operational Standards
ACP conducts its operations within validated pharmaceutical facilities and documented procedures aligned with Good Manufacturing Practice (GMP) requirements. Activities are structured to ensure controlled supply, documented traceability, and regulatory accountability across the product lifecycle.